Abstracts tagged "Disparities"

Abstract Number: 0574 • ACR Convergence 2022
Osteoporosis in Elderly Men; An Underestimated and Underdiagnosed Morbid Entity
Arash Mollaeian¹ and Stanley Ballou², ¹Metro Health Medical Center/Case Western Reserve University, Rocky River, OH, ²Case Western Reserve University - Metro Health, Cleveland, OH
Background/Purpose: 20-25% of osteoporosis-related fractures occur in men and the mortality of osteoporotic fractures is higher in men [1]. Nevertheless, no uniform consensus exists for…
Abstract Number: 1935 • ACR Convergence 2022
Racial Disparities Influence Healthcare Utilization in Pediatric Rheumatology Clinic
William Soulsby¹ and Emily von Scheven², ¹University of California, San Francisco, San Francisco, CA, ²UCSF, San Francisco, CA
Background/Purpose: Racial disparities are prevalent in chronic illness, including pediatric rheumatic diseases. Prior work has investigated the impact of race on disease activity and damage…
Abstract Number: 0104 • ACR Convergence 2022
Gender Representation of the Editors and Editorial Boards of the Top 45 Rheumatology-Focused Journals
Aldo Barajas-Ochoa¹, Amaranta ManriquedeLara², Alfonso Gastelum-Strozzi³, Ingris Pelaez-Ballestas⁴, Antonio Cisneros-Barrios⁵, Manuel Ramirez-Trejo⁵, Paloma Gradilla-Magaña⁵ and Cesar Ramos-Remus⁶, ¹Rutgers New Jersey Medical School., Richmond, VA, ²Hospital General de México "Dr. Eduardo Liceaga,", Ciudad de México, Mexico, ³Universidad Nacional Autónoma de México, Ciudad de México, Mexico, ⁴Hospital General de México "Dr. Eduardo Liceaga", Ciudad de México, Mexico, ⁵Universidad de Guadalajara, Guadalajara, Mexico, ⁶Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico
Background/Purpose: The assessment of the frequency distribution of females and males is occurring in different academic areas. Academic publishing is not exempt from potential structural…
Abstract Number: 0631 • ACR Convergence 2022
Perfluoroalkyl Substances and Community Vulnerability: Associations with Lupus-Related Autoantibodies and Disease
Emily Vara, Dulaney Wilson, John Pearce, Jim Oates and Diane Kamen, Medical University of South Carolina, Charleston, SC
Background/Purpose: Perfluoroalkyl substances (PFAS) are a class of persistent organic pollutants found in nonstick products, water repellant fabrics, fire-retardant foams, and food packaging. Highly stable,…
Abstract Number: 2063 • ACR Convergence 2022
Medication Cost Concerns and Disparities in Patient-reported Outcomes Among a Multiethnic Cohort of Patients with Lupus
Alfredo Aguirre¹, Kimberly DeQuattro², Patricia Katz³, Kurt Greenlund⁴, Kamil Barbour⁴, Caroline Gordon⁵, Cristina M Lanata⁶, Lindsey Criswell⁷, Maria Dall'Era⁸ and Jinoos Yazdany⁹, ¹University of California, San Francisco, San Francisco, CA, ²University of Pennsylvania, Philadelphia, PA, ³UCSF, San Rafael, CA, ⁴Centers for Disease Control and Prevention, Atlanta, GA, ⁵Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, ⁶NIH/NHGRI, Washington, DC, ⁷National Human Genome Research Institute, NIH, Bethesda, MD, ⁸University of California, Division of Rheumatology, San Francisco, CA, ⁹UCSF, San Francisco, CA
Background/Purpose: Medication cost concerns are associated with nonadherence and poor outcomes in the general population. Prior research has described medication cost concerns in up to…
Abstract Number: 0072 • ACR Convergence 2022
Geographical Patterns of Healthcare Utilization Among RA and OA Patients
Sofia Pedro¹, Luke Desilet², Patricia Katz³ and Kaleb Michaud², ¹Forward, The National Databank for Rheumatic Diseases, Wichita, KS, ²University of Nebraska Medical Center, Omaha, NE, ³UCSF, San Rafael, CA
Background/Purpose: Rural residence has been associated with disparities in healthcare-related outcomes in both rheumatic diseases and other chronic conditions. A primary causal pathway for this…
Abstract Number: 0106 • ACR Convergence 2022
A Systematic Review of Racial and Ethnic Disparities in Disease Related Outcomes Among Patients with SLE
Teresa Semalulu¹, Keerthana Pasumarthi¹, Kevin Zhao¹, Rauda AlDhaheri¹, Nadine Akbar², KAREN BEATTIE¹ and KONSTANTINOS TSELIOS³, ¹McMaster University, Hamilton, ON, Canada, ²Humber River Hospital and University of Toronto, Toronto, ON, Canada, ³McMaster University, Population Health Research Institute, Hamilton, ON, Canada
Background/Purpose: Racialized patients and ethnic minorities have worse outcomes in SLE. This is likely related to a complex interplay between genetic and non-genetic factors. Numerous…
Abstract Number: 0728 • ACR Convergence 2022
Racial Disparities in Pain: Severity, Interference with Function, and Response to Guided Imagery
Victoria Menzies and Molly Jacobs, University of Florida, Gainesville, FL
Background/Purpose: Fibromyalgia syndrome (FMS) is a condition characterized by diffuse, widespread, persistent musculoskeletal pain in multiple regions of the body. While FMS is more prevalent…
Abstract Number: 2092 • ACR Convergence 2022
Greater Social Vulnerability Associates with Greater Glucocorticoid Use in Patients with SLE
Avira Som¹, Lily McMorrow¹, Ling Chen¹, Deepali Sen¹, Alia El-Qunni¹, Elizabeth Baker² and Alfred Kim¹, ¹Washington University School of Medicine, St. Louis, MO, ²Saint Louis University College for Public Health and Social Justice, St. Louis, MO
Background/Purpose: Patients with SLE experience substantial health disparities. Studying the effect of spatial context on health outcomes has become a focus in health disparities research.…
Abstract Number: 0085 • ACR Convergence 2022
Closing the Gender Gap in Global Rheumatology Leadership- Are We There Yet?
Tayyeba Khursheed¹, Pavel Ovseiko², Ghita Harifi³, Humeira Badsha⁴, Harish G Shekar⁵ and Latika Gupta⁶, ¹Pakistan Institute of Medical Sciences, Islamabad, Pakistan, ²John Radcliffe Hospital, Oxford, Oxford, United Kingdom, ³Department of Rheumatology, Mediclinic Parkview Hospital, Dubai, United Arab Emirates, ⁴Dr. Humeira Badsha Medical Center, Dubai, United Arab Emirates, ⁵Rajarajeswari medical College and hospital, Bangalore, India, ⁶Royal Wolverhampton Trust, Wolverhampton/University of Manchester, United Kingdom
Background/Purpose: The gender equity in academic rheumatology initiative has sparked discussions on the effect of inequity in academia on assignment to leadership roles. To explore…
Abstract Number: 0107 • ACR Convergence 2022
Short-, Intermediate- and Long-Term Renal Outcomes in Hispanics from Puerto Rico with Lupus Nephritis: Induction Therapy with Cyclophosphamide vs. Mycophenolate Mofetil
Suheiry Márquez, Dahima Cintrón and Luis Vilá, University of Puerto Rico Medical Sciences Campus, San Juan, PR
Background/Purpose: The American College of Rheumatology (ACR) guidelines for the treatment of class III and class IV lupus nephritis (LN) recommend induction therapy with mycophenolate…
Abstract Number: 0744 • ACR Convergence 2022
University of North Carolina and Piedmont Health Collaborative Tele-Rheumatology Project to Optimize Rural Health Specialty Access
Leah Bettner¹, Eli Tiller², John Doughton², Rumey Ishizawar¹ and Alfredo Rivadeneira¹, ¹University of North Carolina at Chapel Hill, Division of Rheumatology, Allergy and Immunology, Thurston Arthritis Research Center, Chapel Hill, NC, ²University of North Carolina Department of Family Medicine, Piedmont Health Services, Chapel Hill, NC
Background/Purpose: Telemedicine can offset barriers rural minority populations face for rheumatology care. However, implementing virtual health technology is challenging as broadband adoption is lower among…
Abstract Number: 2106 • ACR Convergence 2022
Disparities of African American Mortality Trends in South Carolina Lupus Cohort
Sean Carter¹, Dulaney Wilson¹, Samantha Minkin², David Dillon³, Baxter Murray¹ and Jim Oates¹, ¹Medical University of South Carolina, Charleston, SC, ²Vanderbilt University Medical Center, Nashville, TN, ³Rheumatology Associates of South Florida, Delray Beach, FL
Background/Purpose: SLE is a chronic autoimmune disorder associated with increased mortality compared to the general population; treatment for SLE has improved and survival rates have…
Abstract Number: 0086 • ACR Convergence 2022
Patient and Provider Perspectives on Barriers to Communication and Care of Latinx Patients with Lupus and Rheumatoid Arthritis
Monica Crespo Bosque¹, Pablo Weilg Espejo² and Candace Feldman³, ¹Boston University, Boston, MA, ²Boston Medical Center, Chelsea, MA, ³Brigham and Women's Hospital, Boston, MA
Background/Purpose: Latinx patients, a heterogenous population with a range of experiences including migration, language, and race, experience a disproportionate burden of adverse outcomes from systemic…
Abstract Number: 0111 • ACR Convergence 2022
Gender Equity in the Asia Pacific: Comparison of Indian and Philippines Rheumatology Conferences
Lisa S Traboco¹, Geraldine Zamora², Kavitha Mohanasundaram³, Sheila Marie Reyes⁴, Annamalai Sowndhariya⁵, Pavel Ovseiko⁶, vinod Ravindran⁷ and Latika Gupta⁸, ¹St Luke's Medical Center - BGC, Manila, Philippines, ²Philippine Rheumatology Association, Taguig City, Philippines, ³Saveetha Medical College Hospital, Chennai, India, ⁴St. Luke's Medical Center, Cainta, Philippines, ⁵MIOT Hospital, Chennai, India, ⁶John Radcliffe Hospital, Oxford, Oxford, United Kingdom, ⁷Centre for Rheumatology, Kozhikode, Kozhikode, India, ⁸Royal Wolverhampton Trust, Wolverhampton/University of Manchester, United Kingdom
Background/Purpose: Equitable gender representation at conferences is essential to further progress in academia. India and the Philippines are both low and middle-income countries in the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].